AAAAAA
Results: 1-25/26
Authors:
ANTOINE EC
CHOLLET P
MONFARDINI S
SORIO R
AMBROSINI G
BENHAMMOUDA A
MAZEN MF
RAMAZEILLES C
AZLI N
KHAYAT D
Citation: Ec. Antoine et al., SEQUENTIAL ADMINISTRATION OF DOCETAXEL (D) (TAXOTERE(TM)) FOLLOWED BYAC IN FIRST LINE METASTATIC BREAST-CANCER (MBC) PATIENTS (PTS) - FINAL RESULTS, Annals of oncology, 9, 1998, pp. 91-91
Authors:
ORCEL B
ANTOINE EC
BENHAMMOUDA A
VANNETZEL JM
LENSEIGNE S
SOUSSANLAZARD K
LEBRAS E
KHAYAT D
Citation: B. Orcel et al., INTERIM RESULT OF A SEQUENTIAL ADMINISTRATION OF DOCETAXEL FOLLOWED BY CISPLATIN-VINDESINE IN CHEMOTHERAPY NAIVE PATIENTS WITH INOPERABLE NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 458-458
Authors:
KHAYAT D
GILDELGADO M
ANTOINE EC
COEFFIC D
BENHAMMOUDA A
GRAPIN JP
BASTIAN G
Citation: D. Khayat et al., EUROPEAN EXPERIENCE WITH IRINOTECAN PLUS FLUOROURACIL FOLINIC ACID ORMITOMYCIN, Oncology, 12(8), 1998, pp. 64-67
Authors:
KEILHOLZ U
CONRADT C
LEGHA SS
KHAYAT D
SCHEIBENBOGEN C
THATCHER N
GOEY SH
GORE M
DORVAL T
HANCOCK B
PUNT CJA
DUMMER R
AVRIL MF
BROCKER EB
BENHAMMOUDA A
EGGERMONT AMM
PRITSCH M
Citation: U. Keilholz et al., RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 2921-2929
Authors:
TOURANI JM
PFISTER C
BERDAH JF
BENHAMMOUDA A
SALZE P
MONNIER A
PAULE B
GUILLET P
CHRETIEN Y
BREWER Y
DIPALMA M
UNTEREINER M
MALAURIE E
TADRIST Z
PAVLOVITCH JM
HAUTEVILLE D
MEJEAN A
AZAGURY M
MAYEUR D
LUCAS V
KRAKOWSKI I
LARREGAINFOURNIER D
ABOURACHID H
ANDRIEU JM
CHASTANG C
Citation: Jm. Tourani et al., OUTPATIENT TREATMENT WITH SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA ADMINISTRATION IN COMBINATION WITH FLUOROURACIL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA - RESULTS OF A SEQUENTIAL NONRANDOMIZED-PHASE-II STUDY, Journal of clinical oncology, 16(7), 1998, pp. 2505-2513
Authors:
ANTOINE EC
BENHAMMOUDA A
BERNARD A
YOUSSEF A
MORTIER N
GOZY M
NIZRI D
AUCLERC G
ROCHER MA
SOUBRANE CL
WEIL M
KHAYAT D
Citation: Ec. Antoine et al., SALPETRIERE HOSPITAL EXPERIENCE WITH BIOCHEMOTHERAPY IN METASTATIC MELANOMA, The cancer journal from Scientific American, 3, 1997, pp. 16-21
Authors:
TOURANI JM
BENHAMMOUDA A
GUILLET P
PFISTER C
PAULE B
BERBAH JF
CHRETIEN Y
SALZE P
MONNIER A
BREWER Y
Citation: Jm. Tourani et al., SUBCUTANEOUS (SC) INTERLEUKIN-2 (IL-2) PLUS ALPHA-INTERFERON (IFN-ALPHA) AND 5-FLUOROURACIL (5FU) IN OUT-PATIENTS (PTS) WITH METASTATIC RENAL-CELL CARCINOMA (MRCC) - SCAPP-II TRIAL, European journal of cancer, 33, 1997, pp. 150-150
Authors:
ANTOINE EC
ORCEL B
BENHAMMOUDA A
VANNETZEL JM
LENSEIGNE S
SOUSSANLAZARD K
LORET C
BERILLE J
DERENNE JP
KHAYAT D
Citation: Ec. Antoine et al., INTERIM RESULTS OF A SEQUENTIAL ADMINISTRATION OF DOCETAXEL (TAXOTERE(R)) FOLLOWED BY CISPLATIN-VINDESINE IN CHEMOTHERAPY NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 33, 1997, pp. 1085-1085
Authors:
BENHAMMOUDA A
ANTOINE EC
DAOU W
MORTIER N
AUCLERC G
NIZRI D
SOUBRANE C
BASSOT V
WEIL M
KHAYAT D
Citation: A. Benhammouda et al., SYSTEMIC TREATMENT OF METASTATIC MALIGNANT-MELANOMA, European journal of cancer, 33, 1997, pp. 1312-1312
Authors:
RIXE O
COEFFIC D
ORCEL B
MAITRE B
BOREL C
BENHAMMOUDA A
PETIT T
KHAYAT D
DERENNE JP
Citation: O. Rixe et al., A PHASE-II STUDY OF CISPLATIN, 5-FLUOROURACIL, LEUCOVORIN, AND ETOPOSIDE IN ADVANCED NON-SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 20(2), 1997, pp. 128-131
Authors:
COEFFIC D
BENHAMMOUDA A
ANTOINE EC
RIXE O
PARAISO D
AUCLERC G
RENODY N
MULARONI E
SOUBRANE C
WEIL M
MORTIER N
KHAYAT D
Citation: D. Coeffic et al., PRELIMINARY-RESULTS OF A PHASE I II STUDY OF PACLITAXEL, CISPLATIN, AND CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CARCINOMA/, Seminars in oncology, 24(1), 1997, pp. 38-40
Authors:
MOUAWAD R
BENHAMMOUDA A
RIXE O
ANTOINE EC
BOREL C
WEIL M
KHAYAT D
SOUBRANE C
Citation: R. Mouawad et al., ENDOGENOUS INTERLEUKIN-6 LEVELS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - CORRELATION WITH TUMOR BURDEN, Clinical cancer research, 2(8), 1996, pp. 1405-1409
Authors:
MOUAWAD R
SOUBRANE C
BOREL C
RIXE O
BENHAMMOUDA A
WEIL M
KHAYAT D
Citation: R. Mouawad et al., SERUM INTERLEUKIN-6 LEVELS IN METASTATIC MALIGNANT-MELANOMA (MMM) PATIENTS TREATED BY BIOCHEMOTHERAPY - CORRELATION WITH TUMOR BURDEN AND CLINICAL-RESPONSE, The FASEB journal, 10(3), 1996, pp. 2444-2444
Authors:
BENHAMMOUDA A
AUCLERC G
COEFFIC D
WEIL M
NIZRI D
SOUBRANE C
BANZET P
KHAYAT D
Citation: A. Benhammouda et al., CHEMOTHERAPY AND IMMUNOTHERAPY FOR DISSEM INATED MALIGNANT MELANOMAS, La Presse medicale, 25(35), 1996, pp. 1690
Authors:
COEFFIC D
BENHAMMOUDA A
ANTOINE EC
RIXE O
PARAISO D
AUCLERC G
NIZRI D
RENODY N
GRAPIN JP
MULARONI E
RATTINI E
SOUBRANE C
WEIL M
MORTIER N
KHAYAT D
Citation: D. Coeffic et al., PHASE I II STUDY OF PACLITAXEL, CISPLATIN, AND CYCLOPHOSPHAMIDE IN ADVANCED OVARIAN-CARCINOMA - PRELIMINARY-RESULTS/, Seminars in oncology, 23(6), 1996, pp. 5-8
Authors:
RIXE O
BOREL C
PARAISO D
BENHAMMOUDA A
PETIT T
ANTOINE E
BIZZARI JP
AUCLERC G
SOUBRANE C
WELL M
GIROUX B
BANZET P
KHAYAT D
Citation: O. Rixe et al., FOTEMUSTINE, DACARBAZINE, VINDESINE COMBINATION CHEMOTHERAPY IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF 43 PATIENTS, Melanoma research, 5(6), 1995, pp. 419-424
Authors:
RIXE O
BENHAMMOUDA A
FARABOS C
BOREL C
PETIT T
AUCLERC G
COEFFIC D
BASTIAN G
GROSSIN F
PARAISO D
GRAPIN JP
NIZRI D
WEIL M
BISMUTH H
MAHJOUBI M
KHAYAT D
Citation: O. Rixe et al., A PHASE-I STUDY OF CONCOMITANT CPT-11 (C) AND 5FU (F) COMBINATION - PRELIMINARY-RESULTS, European journal of cancer, 31A, 1995, pp. 955-955
Authors:
ANTOINE EC
RIXE O
VUILLEMIN E
BENHAMMOUDA A
BOREL C
GHIRONZI GC
MULARONI E
FRANKS C
AUCLERC G
SOUBRANE C
BANZET P
WEIL M
KHAYAT D
Citation: Ec. Antoine et al., A PHASE-II STUDY OF TAMOXIFEN COMBINED WITH CISPLATIN-INTERLEUKIN-2 AND ALPHA-INTERFERON IN METASTATIC MELANOMA, American journal of clinical oncology, 18(5), 1995, pp. 421-424
Authors:
SMITH MJ
MOUAWAD R
VUILLEMIN E
BENHAMMOUDA A
SOUBRANE C
KHAYAT D
Citation: Mj. Smith et al., PSYCHOLOGICAL SIDE-EFFECTS INDUCED BY INTERLEUKIN-2 ALPHA-INTERFERON TREATMENT, Psycho-oncology, 3(4), 1994, pp. 289-298
Authors:
MOUAWAD R
ICHEN M
KHAVAT D
RIXE O
BENHAMMOUDA A
WEIL M
SOUBRANE O
Citation: R. Mouawad et al., ROLE OF CELLULAR INTERLEUKIN-2 RECEPTORS (IL2R) IN CELL STIMULATION AFTER CHEMOIMMUNOTHERAPY (CI) IN METASTATIC MALIGNANT-MELANOMA (MMM) PATIENTS (PTS), The FASEB journal, 8(5), 1994, pp. 10000998-10000998
Authors:
RIXE O
BENHAMMOUDA A
ANTOINE E
PETIT T
TOURANI JM
BOREL C
FRANKS C
KALIF B
MOUSSEAU M
THOMAS A
BENSFIA S
NIZRI D
SOUBRANE C
HERRERA A
BIZZARI JP
AUCLERC G
WEIL M
BANZET P
KHAYAT D
Citation: O. Rixe et al., CHEMOIMMUNOTHERAPY OF METASTATIC MELANOMA - CISPLATIN, INTERLEUKIN-2 AND IFN-ALPHA IN 91 PATIENTS, Pathologie et biologie, 42(10), 1994, pp. 1080-1081
Authors:
MOUAWAD R
ICHEN M
RIXE O
BENHAMMOUDA A
VUILLEMIN E
WEIL M
KHAYAT D
SOUBRANE C
Citation: R. Mouawad et al., STUDY OF IL-2 RECEPTOR EXPRESSION AFTER CHEMOIMMUNOTHERAPY IN PATIENTS TREATED FOR METASTATIC MALIGNANT-MELANOMA, Clinical and experimental immunology, 97(3), 1994, pp. 342-346
Authors:
SOUBRANE C
MOUAWAD R
ICHEN M
SUISSA J
BOREL C
VUILLEMIN E
BENHAMMOUDA A
BIZZARI JP
WEIL M
KHAYAT D
Citation: C. Soubrane et al., FOLLOW-UP OF SOLUBLE IL-2 RECEPTOR LEVEL IN METASTATIC MALIGNANT-MELANOMA PATIENTS TREATED BY CHEMOIMMUNOTHERAPY, Clinical and experimental immunology, 95(2), 1994, pp. 232-236
Authors:
SOUBRANE C
MOUAWAD R
ICHEN M
BENHAMMOUDA A
RIXE O
WEIL M
KHAYAT D
Citation: C. Soubrane et al., IL2 RECEPTOR EXPRESSION IN METASTATIC MAL IGNANT-MELANOMA PATIENTS TREATED BY BIOCHEMOTHERAPY, Bulletin du cancer, 81(11), 1994, pp. 970-971
Authors:
KHAYAT D
ANTOINE E
RIXE O
TOURANI JM
VUILLEMIN E
BOREL C
BENHAMMOUDA A
THILL L
FRANKS C
AUCLERC G
WEIL M
SOUBRANE C
BANZET P
Citation: D. Khayat et al., CHEMOIMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA THE SALPETRIERE HOSPITAL (SOMPS) EXPERIENCE, European journal of cancer, 29A, 1993, pp. 2-5